/Companies

Abtrace

2 known investors

Find your way into Abtrace

Sign up to see every warm intro you have to Abtrace

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Abtrace team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Abtrace is a proactive monitoring and intelligent recall tool for NHS primary care that reads a practice's clinical record daily to find patients due or overdue for tests, reviews or vaccinations, and automates recall, self-booking, SNOMED coding correction and drug monitoring. It integrates with EMIS Web and TPP SystmOne and is used by GPs, pharmacists, nurses, HCAs and administrators across practices, PCNs and ICBs in England.</parameter> <parameter name="founders">[]

Investors · 2

Faberlisted by FaberLisbon · $108K – $2.7M

How we know: a partner's Signal profile · funding news · techstartups.com · Not right? Tell us

Also in the syndicate · 1

Ganexa Capitallead

Funding

SEC filings, press & company announcements
  • Undisclosed amountseed fundingAug 2021 · 5 sources

    Faber (lead), Ganexa Capital (lead)

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗
Registered name
ABTRACE LIMITED
Company number
11535661
Status
Active
Company type
Private limited company
Incorporated
24 Aug 2018
Registered office
6th Floor, Manfield House, 1 Southampton Street, London, WC2R 0LR
Nature of business (SIC)
62090 — Other information technology service activities
Accounts
last made up to 31 Aug 2025 · next due 31 May 2027
Confirmation statement
last made up to 21 Aug 2025 · next due 4 Sept 2026

Current officers · 3

  • Umar Naeem Ahmad — director, appointed 24 Aug 2018
  • Cristina Correia — director, appointed 24 Aug 2018
  • Helder Tão Ferraz Cardoso Soares — director, appointed 24 Aug 2018

Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Frequently asked questions

What does Abtrace do?
Abtrace is a proactive monitoring and intelligent recall tool for NHS primary care that reads a practice's clinical record daily to find patients due or overdue for tests, reviews or vaccinations, and automates recall, self-booking, SNOMED coding correction and drug monitoring. It integrates with EMIS Web and TPP SystmOne and is used by GPs, pharmacists, nurses, HCAs and administrators across practices, PCNs and ICBs in England.</parameter> <parameter name="founders">[]
Who are Abtrace's investors?
Abtrace's investors include Faber.